Tags

Type your tag names separated by a space and hit enter

Effect of nitric oxide synthase inhibitor and NMDA receptor antagonist on the development of nicotine sensitization of nucleus accumbens dopamine release: an in vivo microdialysis study.
Neurosci Lett. 2006 Dec 06; 409(3):220-3.NL

Abstract

We have previously found that the neuronal nitric oxide synthase inhibitor N-nitro-L-arginine (L-NNA) and the noncompetitive N-methyl-D-aspartate (NMDA) receptor antagonist MK-801 prevent behavioral sensitization to nicotine. This study aimed to investigate the effect of L-NNA and MK-801 on a neurochemical component of nicotine sensitization by evaluating the effect of the drugs on nicotine sensitization of nucleus accumbens dopamine (DA) release. Sprague-Dawley rats were pretreated with L-NNA (15 mg/kg, i.p.), MK-801 (0.3mg/kg, i.p.), or saline 30 min before injection of nicotine (0.4 mg/kg, s.c., once daily) for seven consecutive days. Twenty-four hours after the last drug injection, animals were challenged with local perfusion of 5 mM nicotine into the shell of nucleus accumbens for 60 min and DA release was monitored using in vivo microdialysis. In rats treated with repeated nicotine, acute nicotine challenge induced a greater increase of accumbal DA release than in saline-treated animals (maximal DA response=969+/-235% (mean+/-S.E.M.) of basal level versus 520+/-93%, p=0.042). Co-administration of L-NNA or MK-801 with nicotine attenuated an increase of DA release elicited by acute nicotine challenge, compared with nicotine alone (maximal DA response=293+/-58% and 445+/-90% of basal level, respectively versus 969+/-235%, p=0.004 and p=0.013, respectively). These data demonstrate that L-NNA and MK-801 block the development of nicotine sensitization of nucleus accumbens DA release, further supporting the involvement of nitric oxide and NMDA receptors in the development of behavioral sensitization to nicotine.

Authors+Show Affiliations

Department of Nuclear Medicine, Seoul National University College of Medicine, Seoul, South Korea.No affiliation info availableNo affiliation info availableNo affiliation info available

Pub Type(s)

Journal Article
Research Support, Non-U.S. Gov't

Language

eng

PubMed ID

17046158

Citation

Hong, Soo Kyung, et al. "Effect of Nitric Oxide Synthase Inhibitor and NMDA Receptor Antagonist On the Development of Nicotine Sensitization of Nucleus Accumbens Dopamine Release: an in Vivo Microdialysis Study." Neuroscience Letters, vol. 409, no. 3, 2006, pp. 220-3.
Hong SK, Jung IS, Bang SA, et al. Effect of nitric oxide synthase inhibitor and NMDA receptor antagonist on the development of nicotine sensitization of nucleus accumbens dopamine release: an in vivo microdialysis study. Neurosci Lett. 2006;409(3):220-3.
Hong, S. K., Jung, I. S., Bang, S. A., & Kim, S. E. (2006). Effect of nitric oxide synthase inhibitor and NMDA receptor antagonist on the development of nicotine sensitization of nucleus accumbens dopamine release: an in vivo microdialysis study. Neuroscience Letters, 409(3), 220-3.
Hong SK, et al. Effect of Nitric Oxide Synthase Inhibitor and NMDA Receptor Antagonist On the Development of Nicotine Sensitization of Nucleus Accumbens Dopamine Release: an in Vivo Microdialysis Study. Neurosci Lett. 2006 Dec 6;409(3):220-3. PubMed PMID: 17046158.
* Article titles in AMA citation format should be in sentence-case
TY - JOUR T1 - Effect of nitric oxide synthase inhibitor and NMDA receptor antagonist on the development of nicotine sensitization of nucleus accumbens dopamine release: an in vivo microdialysis study. AU - Hong,Soo Kyung, AU - Jung,In Soon, AU - Bang,Seong Ae, AU - Kim,Sang Eun, PY - 2006/08/29/received PY - 2006/09/21/revised PY - 2006/09/21/accepted PY - 2006/10/19/pubmed PY - 2007/1/5/medline PY - 2006/10/19/entrez SP - 220 EP - 3 JF - Neuroscience letters JO - Neurosci Lett VL - 409 IS - 3 N2 - We have previously found that the neuronal nitric oxide synthase inhibitor N-nitro-L-arginine (L-NNA) and the noncompetitive N-methyl-D-aspartate (NMDA) receptor antagonist MK-801 prevent behavioral sensitization to nicotine. This study aimed to investigate the effect of L-NNA and MK-801 on a neurochemical component of nicotine sensitization by evaluating the effect of the drugs on nicotine sensitization of nucleus accumbens dopamine (DA) release. Sprague-Dawley rats were pretreated with L-NNA (15 mg/kg, i.p.), MK-801 (0.3mg/kg, i.p.), or saline 30 min before injection of nicotine (0.4 mg/kg, s.c., once daily) for seven consecutive days. Twenty-four hours after the last drug injection, animals were challenged with local perfusion of 5 mM nicotine into the shell of nucleus accumbens for 60 min and DA release was monitored using in vivo microdialysis. In rats treated with repeated nicotine, acute nicotine challenge induced a greater increase of accumbal DA release than in saline-treated animals (maximal DA response=969+/-235% (mean+/-S.E.M.) of basal level versus 520+/-93%, p=0.042). Co-administration of L-NNA or MK-801 with nicotine attenuated an increase of DA release elicited by acute nicotine challenge, compared with nicotine alone (maximal DA response=293+/-58% and 445+/-90% of basal level, respectively versus 969+/-235%, p=0.004 and p=0.013, respectively). These data demonstrate that L-NNA and MK-801 block the development of nicotine sensitization of nucleus accumbens DA release, further supporting the involvement of nitric oxide and NMDA receptors in the development of behavioral sensitization to nicotine. SN - 0304-3940 UR - https://www.unboundmedicine.com/medline/citation/17046158/Effect_of_nitric_oxide_synthase_inhibitor_and_NMDA_receptor_antagonist_on_the_development_of_nicotine_sensitization_of_nucleus_accumbens_dopamine_release:_an_in_vivo_microdialysis_study_ L2 - https://linkinghub.elsevier.com/retrieve/pii/S0304-3940(06)01016-0 DB - PRIME DP - Unbound Medicine ER -